Figure 11(b) shows the effects of PTX or ononin on metastasis biomarkers in the tumor tissues. In the cotreatment drug group, the expression levels of N-cadherin and MMP-2 and -9 were noticeably decreased as compared to the single drug treatment (Figure 11(b)). This evidence concerns the gene CDH2 and neoplasm.